Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence and Food Effect Study of Ritlecitinib (PF-06651600) Capsules vs Tablets
NCT04390776Phase 1Completed
- Sponsor
- Pfizer
- Start
- Sep 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ritlecitinib tosilate in alopecia areata (4 arms), sponsored by Pfizer. Primary endpoints: Area under the plasma concentration-time profile from time zero extrapolated to infinite time at Day 2 and Maximum plasma concentration at Day 2. Started Sep 2020; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04390776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04390776.